Chemopreventive Effect of Rebamipide against Gastric Cancer in Patients who undergo Endoscopic Resection for Early Gastric Neoplasms: A Nationwide Claims Study
Conclusion: High-dose rebamipide is associated with reduced gastric cancer risk in high-risk populations who undergo endoscopic resection for early gastric neoplasms.Digestion
Source: Digestion - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | Gastric (Stomach) Cancer | Gastroenterology | Health Insurance | Insurance | Study